Kenvue, the consumer arm of healthcare giant Johnson & Johnson, was valued at $41bn in an upsized initial public offering that marked the biggest US listing in almost 18 months.
Read the full article on the Financial Times website
Kenvue, the consumer arm of healthcare giant Johnson & Johnson, was valued at $41bn in an upsized initial public offering that marked the biggest US listing in almost 18 months.
Read the full article on the Financial Times website
